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INTRODUCTION 
 Glaucoma is a leading cause for blindness in the developing 
countries. It is a preventable cause of blindness and hence it is important 
to create an awareness about this condition.  
 Congenital, juvenile, primary glaucoma and secondary glaucoma 
are the broad classification of glaucomas. There are various types of 
secondary glaucomas like post inflammatory, angle recession, pseudo 
exfoliation, pigmentary glaucoma and lens induced glaucoma etc. 
 With tremendous increase in medical facilities still there is a large 
rural population lacking access to modern medicine due to illiteracy, 
poverty, lack of awareness and therefore lens induced glaucomas are on 
the rise. Hence eye screening camps play a vital role in prompt 
identification of cataract cases before complications develop.  
 In this study we have analyzed the various lens induced glaucomas, 
its visual outcome and intraocular pressure reduction following surgery. 
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ANATOMY 
ANGLE OF THE ANTERIOR CHAMBER: 
Aqueous drainage occurs in the angle of anterior chamber. 
 
FIG1: DIAGRAM SHOWING THE ANGLE STRUCTURES 
Structures present in the angle are: (FIG 1) 
1. Ciliary band 
2. Scleral spur 
3. Trabecular mesh work 
4. Schwalbe ‘s line 
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 CILIARY BAND: 
 Formed by anterior part of the ciliary body between its 
attachment with scleral spur and iris. 
 Wider in myopes, width depends on level of insertion. 
 Appears as a grey or brown band.  
SCLERAL SPUR: 
 Posterior most portion of scleral sulcus. 
 In gonioscopy seen as a prominent white line. 
 It is made of collagen type 1 and 3. 
 On its anterior part corneoscleral trabecular meshwork is 
attached and posteriorly its attached to ciliary body 
TRABECULAR MESHWORK: 
 Seen anterior to scleral spur. 
 Pigmentation in trabecular meshwork increases with age. 
 It is a sieve like structure and it bridges the scleral sulcus and 
converts it into a tube which accommodates the schlemm’s 
canal. 
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 Fibronectin levels in trabecular meshwork increases with age 
and in glaucoma cases. 
 Changes in glycosaminoglycans and glycoprotein levels are 
seen with advancing age and in primary open angle glaucoma 
patients. 
It has three parts: 
1. Uveal meshwork 
2. Corneoscleral meshwork 
3. Juxtacanalicular  / endothelial trabecular meshwork 
 Juxtacanalicular / endothelial trabecular meshwork offers 
maximum resistance to aqueous outflow. 
 The posterior pigmented portion of the trabecular meshwork is the 
active filtering part. 
SCHWALBE’S LINE: 
 Formed by the prominent end of descemet’s membrane of cornea. 
 Seen as a fine ridge in front of trabecular meshwork 
 In gonioscopy a corneal wedge is made to view its position. (14) 
 Pigmented schwalbe’s line seen in pseudo exfoliation and 
pigmentary glaucoma cases. 
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BLOOD AQUEOUS BARRIER 
 It is formed by the tight junctions 
 Between the endothelial cells of the iris capillaries 
 Between the non-pigmented cells of the ciliary 
epithelium. 
 It excludes large molecules from the aqueous and 
normally limits the protein of the aqueous humor to 
less than 1% of its plasma concentration. The normal 
protein concentration of aqueous humor is 13.5 
mg/100ml. 
 The breakdown of the barrier, due to various noxious 
stimuli like prostaglandins in trauma leads to an 
increases aqueous protein concentration. In uveitis, 
when there is extensive breakdown of the barrier, the 
aqueous humor protein level can be greater than 1 
g/100 ml almost similar to that in plasma. 
  In addition to the protein quantification, the 
breakdown of blood aqueous barrier can be evidenced 
clinically by the presence of flare and increased dye 
leakage in this fluorescein angiography. 
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AQUEOUS HUMOR DYNAMICS 
Aqueous humor dynamics includes  
 Aqueous formation 
 Aqueous outflow 
AQUEOUS FORMATION: 
 Aqueous is formed from the ciliary process, mainly from the non 
pigmented epithelium of ciliary process. Rate of formation is 2-2.5 
microlit/min. 
Aqueous humor formation is mainly by  
1. Diffusion 
2. Ultrafiltration 
3. Active secretion 
 Only 10% formation occurs by diffusion. And by ultrafiltration 
20% of formation occurs. 70% of aqueous formation is by active 
secretion. Transport occurs against concentration gradient and energy is 
consumed by active secretion. 
(14)
 
STEPS OF AQUEOUS FORMATION: 
 Formation of stromal pool 
 Active transport of stromal filtrates 
 Passive transport across the non-pigmented  ciliary 
epithelium 
7 
 
FACTORS AFFECTING AQUEOUS HUMOR FORMATION: 
 Age 
 Diurnal variation 
 Physical activity 
 Hypothermia 
 Trauma 
 Inflammation in eyes 
 Hypotension 
 Carotid occlusive disease 
 Drugs : anesthetic agents, systemic anti hypertensive 
drugs 
 Sleep 
AQUEOUS OUTFLOW: 
 Aqueous flows from the posterior chamber to anterior chamber 
through the pupil against slight resistance. 
 In the anterior chamber convection current occurs because the 
anterior part of chamber is cooler due to tear film and avascularity of 
cornea and posterior part is warmer due to warm iris. 
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 Hence aqueous moves upwards along the warmer iris and flows 
downwards in cooler cornea. 
 
FIG 2: DIAGRAM SHOWING AQUEOUS OUTFLOW 
PATHWAYS 
TYPES OF OUTFLOW MECHANISM: 
a) Trabecular outflow( conventional pathway) ( FIG 2) 
b) Uveoscleral outflow( unconventional pathway) 
TRABECULAR OUTFLOW (CONVENTIONAL PATHWAY): 
 75-90% of outflow occurs via this pathway. 
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UVEOSCLERAL OUTFLOW (UNCONVENTIONAL PATHWAY): 
 10-25% of outflow occurs by this pathway 
 Aqueous flows from the site of production to suprachoroidal space 
and drains via the venous circulation. 
 It’s independent of intraocular pressure. 
 This flow occurs because suprachoroidal pressure is 2-4 mmhg less 
than the anterior chamber pressure. 
(14) 
 MMP-1(matrix metallo proteinase-1) plays a role in uveoscleral 
outflow. 
 A prostaglandin analogue increases the uveoscleral outflow. 
 Factors decreasing uveoscleral outflow are miotics, increasing age. 
TRABECULAR MESHWORK 
SCHLEMM ‘S CANAL 
INTRASCLERAL CHANNELS 
EPISCLERAL AND 
CONJUNCTIVAL VEINS 
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EXAMINATION OF A GLAUCOMA CASE 
GLAUCOMA: 
 Glaucoma is a chronic progressive optic neuropathy which is 
characterized by optic nerve head changes and raised intraocular pressure 
and visual field defects. 
Intraocular pressure is the only modifiable risk factor. 
Glaucoma can be broadly classified as  
 Congenital 
 primary open angle/ angle closure glaucoma 
 secondary open angle/ angle closure glaucoma 
 For all glaucoma cases following examination must be done to 
arrive at a diagnosis 
 Visual acuity 
 Intraocular pressure measurement 
 Gonioscopy 
 Examination of optic nerve head 
 Visual field examination 
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INTRAOCULAR PRESSURE MEASUREMENT 
 Intraocular pressure measurement is an important step in all 
glaucoma cases. 
 Various methods for intraocular pressure measurements are used. 
 Intraocular pressure has a diurnal variation and hence the time of 
recording is an important factor. 
 Intraocular pressure measurement at each follow up visit is 
mandatory to decide on the titration of treatment. 
TYPES OF TONOMETERS: 
 Schiotz tonometer 
 Goldmann applanation tonometer( Gold standard) 
 Non contact tonometer 
 Rebound tonometer 
 Mackay marg tonometer 
 Maklakov tonometer 
 Dynamic contour tonometer 
 Ocular response analyser 
 Pressure phosphene tonometer 
 Tono pen 
12 
 
GOLDMANN APPLANATION TONOMETER: 
 It is a Gold Standard method. 
 Measures IOP by providing force which flattens the cornea. 
 Principle: IMBERT  FICKS LAW 
     P = F/A  
P-pressure within a sphere 
F-force needed to flatten a portion of the sphere 
A-area of the sphere which is flattened 
 It is a constant area applanating type of tonometer, it applanates a 
corneal diameter of 3.06mm.( FIG 3) 
 
FIG3: APPLANATION TONOMETER 
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NON CONTACT TONOMETER: 
 It was first introduced by Grolman. 
 A constant force is used to applanate the cornea. 
 This force is directly proportional to the IOP. 
 The time taken from an internal reference point to the moment of 
flattening is measured and its converted to IOP values
(13) 
 A jet of air is used to flatten the cornea. 
 When the reflected light is at peak intensity then the cornea is 
presumed to be flattened.(FIG 4) 
 It is useful in measuring IOP in post-operative patients. 
 Since it’s a non-contact method, less chances of infection. 
  IOP Values are comparable with Goldmann applanation values. 
 
FIG4: NON CONTACT TONOMETER 
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REBOUND TONOMETER: 
 Light, disposable, sterile probe is propelled forward into cornea by 
a solenoid.( FIG 5) 
 Time taken for the probe to return to its resting position and 
characteristics of rebound motion are indicative of IOP. 
 No need for topical anesthesia 
 Can be used in post operative patients 
 Portable and easy to handle device. 
 Risk of infection is less. 
 
FIG5: REBOUND TONOMETER 
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GONIOSCOPY: 
 Gonioscopy is done to study the angle structures. 
 Normally angle of anterior chamber is not visualized due to total 
internal reflection of light rays. 
 This is overcome by using a gonio lens to study the angle. 
 It overcomes the total internal reflection and exceed the critical 
angle (46
o
) by altering the cornea air fluid interface by a tear film 
gonio lens interface
(1)
 
TYPES OF GONIOLENSES: 
DIRECT: 
 Koeppe 
 Barkan 
 Swan Jacob 
 INDIRECT: 
 Goldmann single mirror 
 Goldmann three mirror 
 Zeiss four mirror 
 Posner 
 Sussman four mirror 
 Ritch lens 
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ADVANTAGES OF DIRECT AND INDIRECT LENSES: 
 DIRECT INDIRECT 
1 PANAROMIC VIEW OF 
ANGLE STRUCTURES 
CAN BE SEEN 
EQUIMENT AND 
EXAMINATION 
PROCEDURES ARE 
FAMILIAR 
2 GOOD PATIENT 
COMFORT 
CAN BE DONE QUICKLY 
3 CAN BE USED FOR 
SURGERY 
INDENDATION 
GONIOSCOPY CAN BE DONE 
 
SHAFFER SYSTEM OF ANGLE GRADING: (FIG 6) 
Grade 0 :  closed angle 
Grade S :  slit like angle, <10
o
 
Grade 1 :  extremely narrow, 10
o
(up to schwalbe’s line)  
    
Grade 2 :  moderately narrow, 20
o
, (up to functional trab) 
Grade 3 :  30
 o
, non occludable (up to scleral spur seen) 
Grade 4 :  35
o
-45
o 
non occludable ( up to ciliary body  
   band seen)
(2) 
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FIG 6: PICTURE SHOWING SCHAFFER GRADING OF ANGLE 
VAN HERICK METHOD OF ANTERIOR CHAMBER ANGLE 
MEASUREMENT: 
GRADE 
AC DEPTH AS A 
PROPORTION OF 
CORNEAL THICKNESS 
DESCRIPTION 
4 >=1 AC depth = peripheral 
corneal thickness 
3 1 / 4 – 1/2  AC depth 1 / 4 - 1/2  of 
peripheral corneal thickness 
2 1/4 AC depth 1/4 of peripheral 
corneal thickness 
1 < 1/4 AC depth < 1/4   of 
peripheral corneal thickness 
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FUNDUS EXAMINATION: 
 In glaucoma cases examination of optic nerve head is very 
important. 
OPTIC NERVE HEAD EVALUATION: 
In an optic nerve head the following features has to be examined: 
  Disc size, shape, margins, and colour. 
 Cup size, shape. 
 Cup disc ratio( increased/ asymmetry >0.2 difference between both 
eyes) (FIG 7) 
 Neuroretinal rim (colour / focal notch/thinning/ concentric loss) 
 Retinal nerve fiber layer( wedge /slit defects/ diffuse) 
 Vessel changes like nasalization, bayonetting, barring of circum 
linear vessels 
(1)
 
 Disc hemorrhages 
 Parapapillary area atrophy 
 Laminar dot sign 
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FIG7: PICTURE SHOWING NORMAL AND 
GLAUCOMATOUS ONH 
 In diabetic and hypertensive patients should be screened for 
retinopathy changes. 
 Macular changes should be assessed before any surgery as it 
affects the visual outcome after surgery. 
 Documentation of disc findings at each visit is must to assess 
the progression of glaucoma. 
 The optic nerve head changes and retinal nerve fiber layer 
changes will be corresponding to the field defects. 
EXAMINATION OF VISUAL FIELDS: 
Visual field examination can be done using 
 Kinetic perimetry 
 Static perimetry 
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KINETIC PERIMETRY: 
 Bjerrum target screen is used for kinetic perimetry. 
 The target is moved from non-seeing area to until patient sees the 
target. 
 Targets of different luminance can be used. 
 The brightest target will have largest isopter. (13) 
STATIC PERIMETRY: 
 Automated perimetry is a type of static perimetry. 
 The intensity and size of stimuli can be changed. 
 More reliable and accurate method. 
 Reproducible method of visual field analysis. 
 Visual field progression can be analysed over a period of time. 
 Threshold detection is more sensitive 
 The standardized technology reduces the need for highly trained 
technicians. 
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VISUAL FIELD DEFECTS IN GLAUCOMA: 
 Para central scotoma 
 Nasal step 
 Seidel scotoma 
 Arcuate scotoma 
 Double arcuate scotoma(1) 
  Visual field defects in glaucoma respect horizontal 
meridian. 
 In end stage only a temporal island of vision remains. 
TYPES OF AUTOMATED PERIMETRY: 
 HUMPHREY 
 OCTOPUS 
  OTHER ADVANCED TYPES: 
 SWAP(SHORT WAVE AUTOMATED PERIMETRY) 
 FREQUENCY DOUBLING TECHNOLOGY 
 FLICKER PERIMETRY 
 MOTION DETECTION PERIMETRY 
 MICROPERIMETRY 
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LENS INDUCED GLAUCOMAS 
 Lens induced glaucoma is a type of secondary glaucoma. 
 It can be an open angle or angle closure type. 
 It occurs either due to ageing changes, trauma or congenital 
dislocation/subluxation of lens. 
 Due to lack of knowledge, illiteracy, transportation, lens induced 
glaucoma cases are on rise in rural population. 
 Patients ignore the visual loss and present only when they develop 
symptoms. 
It is of the following types: 
a. Phacolytic glaucoma 
b. Phacomorphic glaucoma 
c. Lens particle glaucoma 
d. Phacoanaphylactic glaucoma 
e. Subluxated/ dislocated lens induced glaucoma 
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PHACOLYTIC GLAUCOMA: 
 Gifford first described the phacolytic glaucoma and its clinical 
presentations. 
 Zeeman and Irvin postulated theories for the development of 
phacolytic glaucoma. 
 Flocks was the first one to use the term “phacolytic glaucoma” in 
1955. 
LENS INDUCED GLAUCOMA 
OPEN ANGLE ANGLE 
CLOSURE 
1. PHACOLYTIC 
2. LENS PARTICLE 
3. PHACOANAPHYLACTIC 
1. PHACOMORPHIC  
2. SUBLUXATED OR 
DISLOCATED LENS 
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PATHOPHYSIOLOGY: 
 Phacolytic glaucoma mostly occurs in mature or hyper mature 
cataract cases. 
 Through the micro pores in anterior lens  capsule, lens proteins 
leak into anterior chamber and these are phagocytosed by 
macrophages. 
 Trabecular outflow obstruction occurs due to macrophages and 
high molecular weight lens proteins. 
 Pathological studies had confirmed this trabecular outflow 
obstruction by demonstrating eosinophilic, protein like material in 
trabecular meshwork in cadaveric eyes. (FIG 8) 
 Due to outflow obstruction of aqueous raised intraocular pressure 
occurs.  
(5)
  
 
FIG 8: HISTOLOGY SHOWING MACROPHAGES IN 
ANGLE 
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CLINICAL FEATURES: 
SYMPTOMS:  
 decreased vision 
 pain and redness 
SIGNS: 
 circumcorneal congestion 
 corneal edema 
 dense cells and flare in anterior chamber 
 normal anterior chamber depth 
 mature / hyper mature cataract with intact anterior capsule( FIG 9) 
 Gonioscopy: open angles are seen. 
 
FIG 9: PHACOLYTIC GLAUCOMA 
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PHACOMORPHIC GLAUCOMA: 
 Phacomorphic glaucoma occurs due to forward displacement of iris 
due to enlarged cataractous lens. 
PATHOPHYSIOLOGY: 
 Phacomorphic glaucoma occurs due to anterior mechanical 
force of lens on to the iris. 
 Lens enlargement occurs due to various factors like age, 
diabetes, diuretics 
(5)
 
 Other factors which cause anterior displacement of lens are 
trauma, zonular weakness due to pseudo exfoliation. 
 The peripheral irido lenticular contact increases. 
 Due to inflammation and iridotrabecular contact, peripheral 
anterior synechiae formation occurs. 
 Mostly within 72 hours of onset of symptoms peripheral 
anterior synechiae formation occurs. 
 Pupillary block can also occur. 
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CLINICAL FEATURES: 
SYMPTOMS: 
 Pain 
 Defective vision 
 Redness 
 Nausea ,vomiting 
 Headache 
SIGNS: (FIG 10) 
 Circum corneal congestion 
 Corneal edema 
 Shallow anterior chamber both central and peripheral 
 Pupil mid dilated, not reacting to light 
 Mature cataract 
 In gonioscopy – angles will be closed and peripheral anterior 
synechiae can be seen. 
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FIG 10: PHACOMORPHIC GLAUCOMA 
LENS PARTICLE GLAUCOMA: 
  Lens particle glaucoma is a type of open angle glaucoma due to 
outflow obstruction. 
PATHOPHYSIOLOGY: 
 Free lens material, cortical matter, macrophages with 
degenerated lens material obstructs the trabecular meshwork. 
(5)
 
 Due to this aqueous outflow obstruction occurs and intraocular 
pressure elevates. 
 Liberation of lens particle can occur due to 
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 spontaneous rupture of anterior lens capsule in mature cataract 
cases 
 Trauma 
 Retained cortical matter after cataract extraction surgery. 
CLINICAL FEATURES: 
SYMPTOMS: 
 Pain and redness 
 Defective vision 
     SIGNS: (FIG 11) 
   Circum corneal congestion 
 Corneal edema 
 White lens particles in anterior chamber 
 Lens debris sticking to endothelium 
 Hyper mature/ mature cataract with anterior capsule rupture. 
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FIG 11: LENS PARTICLE GLAUCOMA 
PHACOANAPHYLACTIC GLAUCOMA: 
 Verhoeff and Lemoine first reported cases of 
hypersensitive reaction to lens protein and termed it as, 
endophthalmitis phacoanaphylactica. 
 Risse reported the clearing of uveitis after removal of 
posterior capsule. 
PATHOPHYSIOLOGY: 
 Lens particles induce a granulomatous inflammatory reaction. 
 Some authors suggest it is due to an immune mediated reaction. 
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 The term phacoanaphylaxis is a misnomer as it does not cause any 
Ig E mediated reaction. 
 It causes mostly open angle glaucoma due to blockage of trabecular 
meshwork with inflammatory products or trabecular meshwork 
inflammation.( FIG 12) 
 Sometimes angle closure also can occur due to peripheral anterior 
synechiae formation. 
 
FIG 12: PAS STAINED SPECIMEN SHOWING L-LENS 
MATERIAL AND Z-ZONAL INFLAMMATION 
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CLINICAL FEATURES: 
SYMPTOMS: 
 Decreased vision 
 Pain and redness 
               SIGNS: 
 Circum corneal congestion 
 Keratic precipitates 
 Anterior chamber cells and flare 
 Hypopyon 
SUBLUXATED/DISLOCATED LENS INDUCED GLAUCOMA: 
 Stellwag first coined the term “Ectopia Lentis” in 1856. 
 Berryat reported a case of bilateral anterior lens subluxation 
way back in 1749. 
 Sichel described the difference between traumatic and 
spontaneous dislocation of lens. 
 Arlt described the congenital factors for dislocation of lens. 
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PATHOPHYSIOLOGY: 
 Due to abnormality in lens zonules, subluxation/ dislocation of lens 
occurs. 
 Most common cause for dislocation/subluxation of lens is trauma. 
 Zonular weakness is also seen in cases of pseudo exfoliation, high 
myopia, uveitis, buphthalmos, intraocular tumors 
  In Congenital syndromes like Marfan’s, homocystinuria, Weill 
marchesani syndrome, Ehler –Danlos syndrome ,ectopia lentis 
occurs. 
(5)
 
 Due to altered lens position pupillary block occurs and raises 
intraocular pressure. 
 Peripheral anterior synechiae may form in cases which are long 
standing. (FIG 13 A&B) 
CLINICAL FEATURES: 
 Subluxated / dislocated lens 
 Iridodonesis 
 Phacodonesis 
 Abnormal zonules 
 Vitreous in pupillary area 
 Gonioscopy shows narrow angles. 
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        FIG 13 A: PICTURE SHOWING SUBLUXATED LENS    
        FIG13 B:PICTURE SHOWING DISLOCATED LENS 
MANAGEMENT 
 In lens induced glaucomas the main stay of treatment is removal of 
lens to reduce the intraocular pressure. 
 Before lens removal intraocular inflammation and intraocular 
pressure should be reduced. 
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PRE-OPERATIVE TREATMENT: 
 All cases should be started on anti-glaucoma medications to 
reduce IOP before surgery. 
 If IOP>30 mmhg is recorded, patients are started on Inj. 
20%Mannitol 200ml IV BD for IOP reduction. 
 Patients are started on topical beta blockers (0.5% Timolol 
eye drops BD) if no systemic contraindications are present. 
 If IOP is still high, then oral carbonic anhydrase inhibitors 
are added. (Tab. Acetazolamide 250mg QID) 
 To reduce inflammation topical steroids are used.  ( 
prednisolone acetate eye drops 6 times a day) 
 In cases of phacolytic, lens particle, phaco anaphylactic 
glaucomas, cycloplegic drugs are used to reduce 
inflammation and relieve ciliary spasm (homatropine eye 
drops BD or cyclopentolate eye drops TDS). 
SURGICAL MANAGEMENT:  
 In lens induced glaucomas lens removal is the main stay of 
treatment. 
 Small incision cataract surgery is mostly done and a posterior 
chamber IOL is implanted. 
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 Extra capsular cataract extraction can also be done with a posterior 
chamber IOL implantation. 
 If peripheral anterior synechiae is present then a combined 
procedure is required. It includes cataract surgery and 
trabeculectomy.  
 In phacomorphic glaucoma if symptoms are present more than 72 
hours a combined procedure is done. Because due to 
iridotrabecular contact and inflammation there is more predilection 
for formation of peripheral anterior synechiae in these cases. 
 In phacomorphic glaucoma, if symptoms are present less than 72 
hours or if PAS is not seen in gonioscopy then a Small incision 
cataract surgery (SICS) with peripheral iridectomy (PI) is done. 
 If a posterior chamber IOL could not be implanted due to a 
posterior capsule rent or vitreous loss then a secondary IOL 
implantation is done in second sitting. 
 Secondary IOL implantation can be an Iris claw lens or a scleral 
fixation lens. 
 Secondary IOL implantation is preferred mostly after inflammation 
resolves. 
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POST-OPERATIVE TREATMENT: 
 All post-operative cases are started on topical antibiotics and 
steroids to reduce inflammation. 
 0.5 %Moxifloxacin eye drops 6 times daily with 
1%prednisolone acetate eye drops 6 times daily is used. 
 In cases of severe post operative iritis subconjunctival 
dexamethasone injection of 0.5cc is given in addition to 
routine drugs. 
 In post-operative iritis cycloplegics are used (cyclopentolate 
eye drops TDS). 
 In cases of striate keratopathy ,  5 %hypertonic sodium 
chloride eye drops is used four times daily. 
 Oral antibiotic drug (Tab.ciprofloxacin 500 mg BD) is given 
for 5 days. 
 Oral anti-inflammatory drugs are also given to reduce the 
pain. 
 Patients are advised to wear dark goggles post operatively to 
prevent any trivial trauma to eye. 
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 Lid hygiene should be maintained post operatively. 
 Drug instillation is demonstrated to the patients and is 
advised to use drops at prescribed intervals. 
 Patients and care takers are advised to wash their hands 
before instillation of drops. 
 Patients should avoid violent coughing, straining, and lifting 
heavy weights during post-operative period. 
 Patients are advised to come for follow up as per the advice 
of the surgeon. 
POST OPERATIVE FOLLOW UP: 
 During each follow up patients best corrected visual acuity is 
checked. 
 Intraocular pressure measurements were done using non-
contact or rebound tonometer. 
 Applanation tonometer is avoided in early post-operative 
period to avoid infections to operated eye. 
 Slit lamp biomicroscopy examination is done to look for any 
signs of inflammation, status of cornea, position of 
intraocular lens, wound site, bleb and status of sutures. 
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 After 6 weeks period gonioscopy is done to analyse the 
angle status. 
 Visual field examination is done after 6 weeks either by 
manual method or by automated perimetry. 
STEPS OF SMALL INCISION CATARACT SURGERY 
 Local anaesthesia was given using 2% xylocaine  mixed  with 
hyaluronidase and adrenaline. Peribulbar block was given. 
 Eye was painted with betadine solution and sterile drape was used. 
 Universal eye speculum was applied.  
 Superior rectus suture was secured and clamped.  
 Conjunctival peritomy done and tenon was separated completely 
and sclera was exposed.  
 Hemostasis was achieved using wet field cautery.  
 A  sclero corneal tunnel incision made. And a side port entry is 
made and anterior capsule stained with trypan blue.(FIG 14&15) 
  Anterior capsulotomy was done by continuous curvilinear 
capsulorrhexis or can opener technique as per surgeon’s 
preference. 
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  Hydrodissection was done but avoided in cases of 
mature/hypermature cataract. 
 Nucleus delivered and cortical matter removed by irrigation and 
aspiration. 
  In case of posterior capsular tear, integrity of capsular bag was 
assessed to place IOL in sulcus.  
 In case of vitreous loss, manual anterior vitrectomy was done. And 
anterior chamber was cleared of vitreous. 
 If there was no complication posterior chamber intraocular lens 
was placed in capsular bag and dialed to place it in position.  
 Visco elastic substance was aspirated  from anterior chamber.  
 Subconjunctival  dexamethasone 0.5cc given at end of procedure. 
 Topical antibiotic drops was applied. 
  Sterile Pad and bandage applied. 
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FIG14: FIGURE SHOWING SCLEROCORNEAL  
TUNNEL IN SICS 
 
FIG 15: PICTURE SHOWING SCLERAL TUNNEL 
CONSTRUCTION IN SICS 
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STEPS OF EXTRACAPSULAR CATARACT 
EXTRACTION: 
 Local anaesthesia was given using 2% xylocaine  
mixed  with hyaluronidase and adrenaline. Peribulbar 
block was given. 
 Eye was painted with betadine solution  and sterile 
drape is used. 
 Universal eye speculum was applied.  
 Superior rectus suture was secured and clamped.  
 Conjunctival peritomy done from 10 o’clock to 2 
0’clock and tenon s separated completely and sclera 
was exposed.  
 Hemostasis was achieved using wet field cautery.  
 Entry into anterior chamber was made and anterior 
capsule was stained with trypan blue. 
 Anterior capsulotomy was done. 
 Corneal entry was extended from 10-2’o clock position 
and nucleus was delivered by pressure counter pressure 
technique. 
 Cortex wash done and IOL placed in bag. 
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 Visco elastic substance was aspirated from anterior 
chamber.  
 Anterior chamber was formed after placing sutures 
with 10-0 nylon.(FIG 16) 
 Subconjunctival  dexamethasone 0.5cc given at end of 
procedure. 
 Topical antibiotic drops  was applied. 
  Sterile  Pad and bandage applied. 
 
 
FIG 16: PICTURE SHOWING ECCE SUTURES 
STEPS OF COMBINED SURGERY: 
 Local anaesthesia was given using 2% xylocaine mixed with 
hyaluronidase and adrenaline. Peribulbar block was given. 
 Eye was painted with betadine solution and sterile drape is used. 
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 Universal eye speculum was applied.  
 Superior rectus suture was secured and clamped.  
 Conjunctival peritomy done to create a fornix based flap and 
tenon’s separated completely and sclera was exposed.  
 Hemostasis was achieved using wet field cautery.  
 A triangular scleral flap is made at 12 o’CP, which is extended till 
the limbus. Size and shape of flap is as per surgeon’s preference. 
  Paracentesis was done and anterior chamber was entered.  
 Anterior capsule stained with tryphan blue and capsulotomy / 
capsulorhexis done.  
 A 1.5-2.5mm wide block of trabecular tissue was excised under the 
sclera flap using a Kelly’s punch. 
 Peripheral iridectomy was done above the site of trabeculectomy 
ostium to avoid plugging of ostium with iris. 
 Scleral tunnel was made and entry was done and extended. 
 Nucleus delivered and cortical matter removed by irrigation and 
aspiration with simcoe cannula. 
 IOL placed in bag. 
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 Scleral flap sutured and water tight closure of conjunctival flap was 
done using 10-0 nylon. 
 Side port was hydrated and formation of bleb was confirmed.( FIG 
17 A &B) 
 Subconjunctival   dexamethasone 0.5cc given at end of procedure. 
 Topical antibiotic drops was applied. 
  Sterile Pad and bandage applied. 
 
 
FIG17 A AND B: PICTURES SHOWING BLEB 
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AIM AND OBJECTIVES 
AIM: 
 To clinically analyse visual outcome and intraocular pressure 
control in lens induced glaucomas following surgery. 
PRIMARY OBJECTIVES: 
To determine the 
 Visual outcome 
 Intraocular pressure control following surgery in cases of lens 
induced glaucomas. 
SECONDARY OBJECTIVES: 
 To study the surgical complications and reasons for reduced visual 
acuity following manual small incision cataract surgery /ECCE/ 
combined surgery/lens removal with secondary IOL in cases of 
lens induced glaucomas. 
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MATERIALS AND METHODS 
SUBJECT SELECTION:   
 100 patients with LENS INDUCED GLAUCOMA attending 
glaucoma services of Regional Institute of Ophthalmology and 
Government Ophthalmic Hospital were included in the study. 
INCLUSION CRITERIA: 
 Patients with phacolytic glaucoma / phacomorphic glaucoma/ 
phacoanaphylaxis /lens particle glaucoma/ any subluxated or dislocated 
lens with raised IOP. 
EXCLUSION CRITERIA: 
 Patients under the age of 18. 
 Patients with primary open angle glaucoma and primary angle 
closure glaucoma. 
 Patients with other secondary glaucomas. 
 Patients with uncontrolled diabetes, hypertension, ischemic heart 
disease. 
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EXAMINATION METHODS: 
All were subjected to 
 Anterior segment examination by slit lamp bio microscopy. 
 Best corrected visual acuity by Snellen chart. 
 Intraocular pressure measurement either by Goldmann applanation 
tonometry or in cases with presence of corneal edema  rebound 
tonometry reading was recorded. 
 Fundus examination and in cases with no view of fundus  
     B scan will be done  
 Gonioscopic examination with Goldmann single mirror lens. 
 In cases of lens subluxation, an Ultrasound Biomicroscopy (UBM) 
will be done to know the degree of zonular dehiscence. 
 Routine investigations like Blood sugar, Urine analysis, blood 
pressure measurement will be done. 
 Keratometry, Axial length, IOL power will be calculated in 
patients undergoing surgery. 
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FOLLOW UP: 
 Patient undergoing cataract / combined surgery/lens removal with 
secondary IOL will be under follow up for 6 weeks {post op day 
1, 3, 7, and in end of 2nd, 4th and 6th week}. 
 At each visit visual acuity measurement, anterior segment 
examination by slit lamp, intraocular pressure by non-contact 
tonometer / rebound tonometer and fundus examination will be 
done . 
 End of one month gonioscopy is repeated and field examination 
is done with automated perimetry/ manual fields. 
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RESULTS 
1. AGE DISTRIBUTION: 
AGE  IN YEARS 
NO.OF 
PATIENTS 
PERCENTAGE 
51-55 15 15 
56-60 52 52 
61-65 16 16 
66-70 15 15 
71-75 1 1 
76-80 1 1 
 
TABLE1: SHOWING AGE DISTRIBUTION OF PATIENTS 
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 In our study, among the 100 cases,15 cases presented between age 
group 51-55years, 52 cases in age group 56-60years,16 cases in age 
group 61-65 years, 15 cases in age group 66-70 years,1 case in age group 
71-75,1 case in age group 76-80years. 
Maximum numbers of cases (52%) were in the age group of 56 -60 years. 
2. SEX DISTRIBUTION: 
SEX NO.OF PATIENTS PERCENTAGE 
MALE 59 59 
FEMALE 41 41 
 
TABLE2: TABLE SHOWING THE SEX DISTRIBUTION 
 
CHART2: CHART SHOWING THE SEX DISTRIBUTION 
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Among the 100 cases in this study, 59% were males and 41% 
were females. 
3. VISION AT THE TIME OF PRESENTATION: 
VISION NO OF EYES PERCENTAGE 
1/60 1 1 
HM 48 48 
PL 51 51 
 
TABLE 3: TABLE SHOWING THE VISION OF THE PATIENTS 
AT THE TIME OF PRESENTATION 
 
CHART3: CHART SHOWING THE VISION OF THE PATIENTS 
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 In our study out of 100 cases, 51% patients presented with a vision 
of perception of light(PL), 48% patients presented with a vision of hand 
movements(HM), 1% patients presented with a vision of reading at 1 
meter distance(1/60) 
4. IOP AT THE TIME OF PRESENTATION: 
IOP RANGE 
(mmhg) 
NO OF EYES PERCENTAGE 
22-26 18 18 
28-32 47 47 
34-38 23 23 
40-44 12 12 
 
TABLE 4: TABLE SHOWING IOP AT THE TIME OF 
PRESENTATION  
 
 
 
 
 
 
 
CHART4: CHART SHOWING IOP AT THE TIME OF 
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 In our study, among 100 cases, 18% cases presented in an  IOP 
range of 22-26 mmhg, 47%cases presented in IOP range of 28-
32mmhg,23% cases presented in IOP range of 34-38mmhg, 12%cases 
presented in IOP range 40-44mmhg. 
Maximum cases (47%) presented with an IOP of 28-32mmhg. 
5. PERCENTAGE OF VARIOUS LENS INDUCED 
GLAUCOMA: 
TYPE OF GLAUCOMA 
NO OF 
EYES 
PERCENTAGE 
PHACOLYTIC GLAUCOMA 
(PLG) 
60 60 
PHACOMORPHIC 
GLAUCOMA(PMG) 
29 29 
LENS PARTICLE 
GLAUCOMA(LPG) 
10 10 
SUBLUXATED LENS INDUCED 
GLAUCOMA(SLIG) 
01 01 
 
TABLE 5: TABLE SHOWING % OF VARIOUS LENS INDUCED 
GLAUCOMAS 
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CHART 5: CHART SHOWING % OF VARIOUS LENS INDUCED 
GLAUCOMAS 
 
 In our study, among 100 cases of  lens induced glaucomas, 60% 
cases were phacolytic glaucomas(PLG),29% were phacomorphic 
glaucomas(PMG),10% were lens particle  glaucomas(LPG),1% was due 
to subluxated lens induced glaucoma(SLIG). 
6. LENS STATUS IN AFFECTED EYE: 
LENS STATUS 
NO OF 
EYES 
PERCENTAGE 
HYPERMATURE CATARACT 
(HMC) 
50 50 
MATURE CATARACT(MC) 49 49 
IMMATURE CATARACT (IMC)-
SUBLUXATED LENS 
01 01 
 
TABLE 6: TABLE SHOWING LENS STATUS IN AFFECTED EYE 
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CHART 6: CHART SHOWING LENS STATUS IN AFFECTED 
EYE 
 
 In our study, among 100 affected eyes, 50% had hyper mature 
cataract, 49% had mature cataract, 1% had immature cataract with 
subluxation. 
7. LENS STATUS IN OTHER EYE: 
LENS STATUS NO OF EYES PERCENTAGE 
POSTERIOR CHAMBER IOL 
(PCIOL) 
72 72 
IMMATURE CATARACT (IMC) 28 28 
 
 
TABLE 7: TABLE SHOWING THE LENS STATUS IN OTHER 
EYE OF THE PATIENT 
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CHART 7: CHART SHOWING THE LENS STATUS IN OTHER 
EYE OF THE PATIENT 
 
 In our study, among 100 cases, the unaffected other eye had 
Posterior chamber IOL (PCIOL) in 72% of cases and immature cataract 
in 28%. 
 Maximum cases  (72%) had PCIOL in other eye. 
8. VISUAL ACUITY IN OTHER EYE: 
VISUAL ACUITY 
IN OTHER EYE 
NO.OF EYES PERCENTAGE 
3/60-6/60 8 8 
6/36-6/18 57 57 
6/12-6/9 35 35 
TABLE8: TABLE SHOWING VISUAL ACUITY IN OTHER EYE 
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CHART8: CHART SHOWING VISUAL ACUITY IN OTHER EYE 
 In our study, among 100 cases, visual acuity in other eye was in the 
range 3/60-6/60 in 8% cases, 6/36-6/18 in 57% cases, 6/12-6/9 in 35% 
cases. 
 Maximum number of cases (57%) had a visual acuity in 6/36-6/18 
range. 
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9. TYPE OF SURGERY DONE: 
TYPE OF SURGERY 
NO OF 
EYES 
PERCENTAGE 
COMBINED SURGERY (COMB) 15 15 
EXTRA CAPSULAR CATARACT 
EXTRACTION (ECCE) 
16 16 
SMALL INCISION CATARACT 
SURGERY(SICS) 
54 54 
SMALL INCISION CATARACT 
SURGERY WITH  
PERIPHERAL IRIDECTOMY 
(SICS+PI) 
10 10 
SMALL INCISION CATARACT 
SURGERY WITH  
LENS REMOVAL (SICS+LR) 
05 05 
 
TABLE 9: TABLE SHOWING TYPE OF SURGERY DONE IN 
LENS INDUCED GLAUCOMA 
 
 
CHART 9: CHART SHOWING TYPE OF SURGERY DONE 
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 In our study, among 100 cases of lens induced glaucomas, 15% of 
cases were taken up for combined surgery(SICS with Trabeculectomy), 
16% of cases were taken up for Extra capsular cataract extraction 
(ECCE),54%of cases were taken up for small incision cataract 
surgery(SICS),10% of cases were taken up for small incision cataract 
surgery with peripheral iridectomy (SICS+PI), 5% of cases were taken 
up for small incision cataract surgery with lens removal (SICS+LR). 
10. IOL IMPLANTATION: 
IOL NO OF EYES PERCENTAGE 
APHAKIA 5 5 
PCIOL 95 95 
 
TABLE 10: TABLE SHOWING IOL STATUS OF PATIENTS 
POST OPERATIVELY 
 
CHART 10: CHART SHOWING IOL STATUS OF PATIENTS 
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 In our study, among 100 eyes which were operated   95% cases 
posterior chamber IOL (PCIOL) was implanted, 5% of cases were 
left aphakic due to complications. 
11. SURGICAL COMPLICATIONS: 
 
CHART 11 A: CHART SHOWING % OF STRIATE 
KERATOPATHY 
 In our study, among 100 eyes operated 68% of cases had striate 
keratopathy post operatively. 
 
CHART 11 B: CHART SHOWING % OF POST OPERATIVE 
IRITIS 
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 In our study, among 100 eyes operated, post-operative iritis was 
present in all cases (100%). 
 
CHART 11 C: CHART SHOWING % OF ZONULAR   
DEHISCENCE 
 In our study, among 100 eyes operated, zonular   dehiscence 
occurred in 43% cases. 
 
 
 
 
 
CHART 11 D: CHART SHOWING % OF POSTERIOR 
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 In our study, among 100 eyes operated 12% cases had posterior 
capsular rent. 
 
CHART 11 E: CHART SHOWING % OF VITREOUS LOSS 
 In our study, among 100 eyes operated, 5% cases had vitreous 
loss. 
12. POST OPERATIVE VISUAL OUTCOME: 
VISION POD 1 POD 3 POD 7 
PO 2
ND
 
WEEK 
PO 4
TH
 
WEEK 
PO 6
TH
 
WEEK 
HM-2/60 28% 16% 5% 5% 5% 5% 
3/60-6/60 72% 84% 75% 52% 35% 20% 
6/36-6/18 0 0 20% 38% 45% 55% 
6/12-6/9 0 0 0 5% 15% 20% 
 
TABLE 11: TABLE SHOWING VISUAL ACUITY IN POST 
OPERATIVE PERIOD 
VITREOUS LOSS 
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In our study, among 100 cases: 
 Visual acuity on POST-OPERATIVE DAY 1: 28% cases had 
vision of  range HM-2/60 {HM- 5%; 1/60-9% ; 2/60 -14%} , 72% 
cases had vision of range 3/60-6/60{ 3/60- 16%; 4/60-25%;5/60- 
21%;6/60-10%} 
 Visual acuity on POST-OPERATIVE DAY 3: 16%   cases had 
vision of  range HM-2/60{HM- 1%; 1/60-9% ; 2/60 -6%} 
,84%cases had vision of range 3/60-6/60{ 3/60- 21%; 4/60-
14%;5/60- 15%;6/60-34%} 
 Visual acuity on POST-OPERATIVE DAY 7: 5%   cases had 
vision of  range HM-2/60{HM- 0%; 1/60-5% ; 2/60 -0%} ,75% 
cases had vision of range 3/60-6/60{ 3/60- 10%; 4/60-17%;5/60- 
10%;6/60-38%} ,20%cases had vision of  range 6/36-6/18{6/36-
15%;6/24-5%;6/18-0%} 
 Visual acuity on POST-OPERATIVE 2ND WEEK : 5%   cases 
had vision of  range HM-2/60{HM- 0%; 1/60-5% ; 2/60 -0%} 
,52% cases had vision of range 3/60-6/60{ 3/60- 0%; 4/60-
10%;5/60- 5%;6/60-37%} ,38% cases had vision of  range 6/36-
6/18{6/36-28%;6/24-10%;6/18-0%},5%cases had vision of  
range6/12-6/9{ 6/12-5%,6/9-0%} 
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 Visual acuity on POST-OPERATIVE 4th WEEK : 5%   cases 
had vision of  range HM-2/60{HM- 0%; 1/60-5% ; 2/60 -0%} 
,35% cases had vision of range 3/60-6/60{ 3/60- 0%; 4/60-
0%;5/60- 5%;6/60-30%} ,45% cases had vision of  range 6/36-
6/18{6/36-25%;6/24-20%;6/18-0%},15% cases had vision of  
range 6/12-6/9{ 6/12-15%,6/9-0%} 
 Visual acuity on POST-OPERATIVE 6th WEEK : 5%   cases 
had vision of  range HM-2/60{HM- 0%; 1/60-5% ; 2/60 -0%} 
,20% cases had vision of range 3/60-6/60{ 3/60- 0%; 4/60-
0%;5/60- 5%;6/60-15%} ,55% cases had vision of  range 6/36-
6/18{6/36-35%;6/24-10%;6/18-10%},20% cases had vision of  
range 6/12-6/9{ 6/12-20%,6/9-0%}. 
 
CHART 12: CHART SHOWING THE VISUAL OUTCOME IN 
EACH POSTOPERATIVE DAY /WEEK 
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13. POST OPERATIVE IOP CONTROL: 
IOP 
(mmhg) 
POD 1 POD 3 POD 7 
PO 2
ND
 
WEEK 
PO 4
TH
 
WEEK 
PO 6
TH
 
WEEK 
12-14 26% 26% 42% 54% 60% 60% 
16-18 49% 57% 42% 41% 40% 40% 
20-22 25% 17% 16% 05% 0 0 
 
TABLE 12: TABLE SHOWING IOP REDUCTION IN POST 
OPERATIVE  PERIOD 
In our study among 100 cases, 
 On post-operative day 1, intraocular pressure( IOP) was in the 
range of 12-14mmhg in 26% cases,16-18mmhg in 49% cases,20-
22mmhg in 25% cases. 
 On post-operative day 3, intraocular pressure( IOP) was in the 
range of 12-14mmhg in 26% cases,16-18mmhg in 57% cases,20-
22mmhg in 17% cases. 
 On post-operative day 7 ,intraocular pressure( IOP) was in the 
range of 12-14mmhg in 42%cases,16-18mmhg in 42% cases,20-
22mmhg in 16% cases. 
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 On post-operative 2ndweek, intraocular pressure( IOP) was in the 
range of 12-14mmhg in 54% cases,16-18mmhg in 41% cases,20-
22mmhg in 5% cases. 
 On post-operative 4th week, intraocular pressure( IOP) was in the 
range of 12-14mmhg in 60% cases,16-18mmhg in 40% cases,20-
22mmhg in 0% cases. 
 On post-operative 6th week, intraocular pressure( IOP) was in the 
range of 12-14mmhg in 60% cases,16-18mmhg in 40% cases,20-
22mmhg in 0% cases. 
 
CHART 13: CHART SHOWING THE IOP REDUCTION IN EACH 
POSTOPERATIVE DAY/WEEK 
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14. VISUAL FIELD EXAMINATION: 
 
CHART14: CHART SHOWING POSTOPERATIVE VISUAL 
FIELD EXAMINATION OF PATIENTS 
 
 In our study, among 100 cases, at the end of 6
th 
post-operative 
week visual field examination showed 95% with normal visual field,5% 
of patients it could not be tested due to poor visual acuity. 
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DISCUSSION 
1) Age: In our study, Maximum numbers of cases (52%) were in the 
age group of 56 -60 years. In a study done by venkatesh prajna et 
al(1996) age group range was 43 -80years
(16)
. 
2) Sex: In our study there was a slight male preponderance (59%). 
Previous studies showed a slight female preponderance but it was 
not statistically significant
 (16)
. Sex does not affect the disease 
process or the treatment in lens induced glaucoma cases. 
3) Vision at the time of presentation: Among  100 cases,51% 
patients presented with a vision of perception of light(PL), 48% 
patients presented with a vision of hand movements(HM), 1% 
patients presented with a vision of reading at 1 meter 
distance(1/60). Maximum number of cases presented with a very 
poor vision due to mature cataract and corneal edema. In previous 
studies 90% cases presented with perception of light vision
(18)
 
4) IOP at the time of presentation: Maximum cases (47%) 
presented with an IOP of 28-32mmhg. IOP reduction should be 
done with medication before taking up for surgery. In a study done 
by venkatesh prajna et al (1996), IOP range was 22-70 mmhg
 (16)
. 
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5) Type of lens induced glaucoma: In our study, among 100 cases of 
lens induced glaucomas, 60% cases were phacolytic glaucomas, 
29% were phacomorphic glaucomas, 10% were lens particle  
glaucomas, 1% was due to subluxated lens induced glaucoma. 
Most of the previous studies were done only on phacolytic and 
phacomorphic glaucomas
(16)(20)(25)(28)
 
6) Lens status in affected eye: In our study, among 100 affected 
eyes, 50% had hyper mature cataract, 49% had mature cataract, 1% 
had immature cataract with subluxation. Maximum cases had a 
hyper mature cataract. Previous studies also shows 92% cases were 
presenting with hyper mature cataract
(20) 
7) Lens status in other eye: In our study, Maximum cases (72%) had 
PCIOL in other eye. This was an important factor for late 
presentation to the hospital. Since patient was operated in other eye 
and had good vision they ignored the visual loss of the fellow eye 
and presented to hospital only when they had symptoms like pain 
and redness. 
8) Visual acuity in other eye: Maximum number of cases (57%) had 
a visual acuity in 6/36-6/18 range and 6/12-6/9 in 35% cases. 
Because of good vision in other eye most of the patients are 
comfortable with the routine activity and presented late to hospital 
only when they developed pain and redness. 
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9) Type of surgery done: In our study, among 100 cases of lens 
induced glaucomas, 15% of cases were taken up for combined 
surgery(SICS with Trabeculectomy), 16% of cases were taken up 
for  Extra capsular cataract extraction (ECCE),54% of cases were 
taken up for small incision cataract surgery(SICS),10% of cases 
were taken up for small incision cataract surgery with peripheral 
iridectomy (SICS+PI), 5% of cases were taken up for small 
incision cataract surgery with lens removal (SICS+LR). The type 
of surgery depends on the type of lens induced glaucoma and 
decided on the patient’s individual condition. 
10)IOL implantation: In our study, postoperatively 95% cases 
posterior chamber IOL was implanted, 5% cases were left aphakic 
due to surgical complications and planned for secondary IOL 
implantation in second sitting after inflammation reduces. 
The choice of secondary IOL can be iris claw lens or a scleral 
fixation lens. 
11)Surgical complications: 
 68% of cases had striate keratopathy. 
 Post-operative iritis was present in all cases (100%) 
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 zonular  dehiscence occurred in 43% cases,  
 12% cases had posterior capsular rent and 5% cases had 
vitreous loss. 
All these complications caused reduced visual acuity in early 
post-operative period. Patients who had corneal endothelial 
touch during surgery developed striate keratopathy post 
operatively and were treated with 5% hypertonic sodium 
chloride eye drops 4 times daily. 
In cases of severe post-operative iritis, subconjunctival 
dexamethasone injection of 0.5cc is given, cycloplegics were 
used (cyclopentolate eye drops TDS). 
12)Post-operative visual outcome: 
At the end of six weeks the visual acuity for maximum number of 
cases (55%) was in the range 6/36-6/18, 20% cases had vision of 
range 3/60-6/60, 20% cases had vision of range 6/12-6/9. Hence 
visual improvement occurred in 95% of cases at the end of sixth 
post-operative week. This is a statistically significant (p<0.5) 
improvement.  
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 Among the 20% cases with a vision of 6/12, 15% were 
phacolytic glaucoma, 5% were lens particle glaucoma. 
 Out of 10 lens particle glaucoma cases, 50 %( 5 cases) had 
a good vision of 6/12 when compared to other types of lens 
induced glaucoma. 
 5% of cases had reduced vision due to aphakia and all the 5 
cases had a vision in range of 6/18-6/12 with +10DSph 
correction hence, planned for a secondary IOL implantation 
later after inflammation subsides. 
13) IOP reduction: at the end of 6th post-operative week, 
intraocular pressure (IOP) was in the range of 12-14mmhg in 60% 
cases, 16-18mmhg in 40% cases. 
Hence 100% cases had reduction in intraocular pressure following 
surgery in lens induced glaucoma. Hence surgery is the gold 
standard treatment for all lens induced glaucomas. 
14) Visual field examination: Among 100 cases, at the end of 6th 
post-operative week visual field examination showed 95% with 
normal visual field,5% of patients it could not be tested due to poor 
visual acuity. Since all cases are promptly treated on time and 
intraocular pressure was controlled visual field loss was prevented. 
  
74 
 
CONCLUSION 
 Lens induced glaucoma occurs due to long standing 
cataractous lens which becomes hyper mature/mature and 
also due to trauma. 
 In our study, most of the patients had good vision in fellow 
eye and PCIOL status. This shows that patients ignored the 
reduced vision in affected eye due to good vision in fellow 
eye so their daily life was not affected until they developed 
symptoms. 
 Hence it is important to educate the patient postoperatively, 
to regularly follow up and examine the fellow eye and 
advice cataract surgery promptly before complications 
develop. 
 Most of the patients present with lens induced glaucoma 
were from a rural area where the surgical facilities are not 
easily available. 
 Eye camps should be conducted in remote villages and 
screened for cataract and operated before complications 
occur. 
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 In lens induced glaucoma, surgery is the main stay of 
treatment after adequate control of intraocular pressure and 
inflammation with medications. 
 Following surgery, intraocular pressure reduction occurs in 
all cases and visual improvement occurs in 95% cases. 
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GLAUCOMA DUE TO SUBLUXATED LENS 
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POST OP FOURTH WEEK 
 
POST OP SIXTH WEEK 
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POST OPERATIVE PICTURE SHOWING  
THE BLEB STATUS 
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PROFORMA 
CASE NUMBER: 
1. Name:                   Age/sex :                        Mobile no:   
OP No/Date: 
Place:      
2.  Symptoms: ( Duration )  
Defective vision 
Pain  
Redness  
Photophobia 
Any other symptoms: 
3.  Past history -   History of any intraocular surgery/trauma  
4.  Medical history - diabetes /hypertension/IHD/bronchial 
 asthma/chronic disease/steroid usage (long term) 
5.  Family history-similar history in family    (subluxated /dislocated  
 lens  in non-traumatic cases) 
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6.  Ocular Examination:   
          RE        LE 
Lids   
Conjunctiva   
Cornea   
Ant chamber: 
Depth 
Cells/flare 
Lens  particles 
  
Iris    
Pupil: 
Size shape reaction 
  
Lens : 
 
Immature 
Mature 
Hypermature 
Subluxated 
dislocated 
Immature 
Mature 
Hypermature 
Subluxated 
dislocated 
 
Gonioscopy: Schaffer   RE                                       LE 
Vision: (BCVA) 
RE:                         LE: 
Intraocular pressure: 
(GAT/Rebound tonometry)RE:        LE: 
 Fundus: RE: media:               disc and vessels: 
               LE: media:                 disc and vessels: 
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Diagnosis: 
Surgical details: Nature of surgery   Manual SICS/ ECCE/ Combined / 
lens removal with secondary IOL 
Complications:-  1.  Corneal endothelial injury (striate keratopathy)                               
2.Zonular dehiscence 3.PC rent     4.Vitreous loss     5.Post op iritis 
Post op vision (BCVA) :  
Day 1                       Day 3                       Day 7 
Post op IOP: (NCT) 
Day 1                       Day3                              Day 7 
Follow up visits:   2nd week           4th week        6th week 
 Visual acuity      
Anterior segment     
 Fundus     
 IOP    
Gonioscopy 
Fields (AP/ manual) 
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KEY TO MASTER CHART 
RE - RIGHT EYE, LE – LEFT EYE 
IP NO – IN PATIENT NO 
SEX: 
M - MALE  
F - FEMALE  
CORNEA: 
C – CLEAR 
 E – EDEMA 
VISION AND INTRAOCULAR PRESSURE: 
HM- HAND MOVEMENTS 
PL-PERCEPTION OF LIGHT 
IOP-INTRAOCULAR PRESSURE 
GONIOSCOPY: 
0,1,2,3 – SHAFFER’S GRADING 
PAS-PERIPHERAL ANTERIOR SYNECHIAE 
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NV-NO VIEW 
ANTERIOR CHAMBER (A.C) : 
ND – NORMAL DEPTH  
S – SHALLOW  
C- CELLS + 
F-   FLARE+ 
LP- LENS PARTICLES 
PUPIL: 
RTL- REACTING TO LIGHT 
NRTL- NOT REACTING TO LIGHT 
 FUNDUS: 
NV-NO VIEW 
VH – VIEW HAZY 
CD – CUP DISC RATIO 
BSCAN: 
N- NORMAL 
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LENS: 
IMC – IMMATURE CATARACT  
MC – MATURE CATARACT 
HMC – HYPER MATURE CATARACT   
PCIOL - POSTERIOR CHAMBER IOL 
SL – SUBLUXATED LENS 
DIAGNOSIS: 
PLG-PHACOLYTIC GLAUCOMA 
PMG-PHACOMORPHIC GLAUCOMA 
LPG-LENS PARTICLE GLAUCOMA 
SLIG (SL)-SECONDARY LENS INDUCED GLAUCOMA DUE TO 
SUBLUXATED LENS 
SURGERY:  
SICS – SMALL INCISION CATARACT SURGERY 
ECCE- EXTRA CAPSULAR CATARACT EXTRACTION 
 PI – PERIPHERAL IRIDECTOMY  
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COMB- COMBINED SURGERY (SICS+TRAB) 
SURGICAL COMPLICATIONS: 
SK-STRIATE KERATOPATHY 
ZD – ZONULAR DEHISCENCE 
PCR – POSTERIOR CAPSULAR RENT 
VL – VITREOUS LOSS 
POI – POSTOP IRITIS 
 FIELDS: 
N- NORMAL 
NP- NOT POSSIBLE 
 
 
 
 
SK POI ZD VL PCR VN IOP VN IOP VN IOP VN IOP VN IOP VN IOP
1 SUBBARAO 56 M 65340 RE HM 30 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS + + + - - PCIOL 3/60 14 6/60 12 6/24 12 6/12 12 6/12 12 6/12 12 N
LE 6/12 12 C ND RTL PCIOL 3 0.3
2 ADIMOOLAM 57 M 12453 RE PL 26 E ND C+F+ SRTL MC NV NV N RE PLG SICS + + - - - PCIOL 2/60 14 3/60 14 6/60 14 6/36 14 6/24 12 6/12 12 N
LE 6/18 14 C ND RTL PCIOL 3 0.3
3 BAGAVATHY 60 F 92143 RE 6/12 14 C ND RTL IMC 3 0.3
LE HM 28 E S NRTL MC 1 PAS NV N LE PMG COMB + + + - + PCIOL 1/60 18 3/60 18 5/60 18 6/36 16 6/36 16 6/36 16 N
4 VELLAPAN 58 M 1267 RE 6/24 12 C ND RTL IMC 3 0.3
LE HM 30 E ND C+F+ NRTL HMC NV NV N LE PLG SICS + + - - - PCIOL 4/60 14 6/60 14 6/36 12 6/24 12 6/24 12 6/18 12 N
5 MYTHILI 56 F 1468 RE PL 26 E ND C+F+ NRTL MC NV NV N RE PLG SICS + + - - - PCIOL 3/60 12 3/60 12 4/60 12 6/60 12 6/36 12 6/36 12 N
LE 6/12 14 C ND RTL PCIOL 3 0.3
6 MUNUSAMY 62 M 37860 RE 6/24 16 C ND RTL PCIOL 3 0.3
LE HM 28 E ND C+F+ NRTL MC NV NV N LE PLG SICS + + - - - PCIOL 1/60 16 1/60 16 3/60 16 5/60 14 6/60 14 6/36 14 N
7 PARVATHY 66 F 2459 RE PL 26 E ND C+F+ NRTL HMC NV NV N RE PLG SICS - + - - - PCIOL 4/60 14 6/60 12 6/36 12 6/36 12 6/12 12 6/12 12 N
LE 6/9 18 C ND RTL PCIOL 3 0.3
8 MURALI 58 M 7890 RE HM 32 E S NRTL MC 1 PAS NV N RE PMG COMB + + - - - PCIOL 3/60 16 4/60 16 6/60 14 6/36 14 6/36 14 6/36 14 N
LE 6/18 18 C ND RTL PCIOL 3 0.3   
9 KUMARVEL 68 M 12367 RE 5/60 16 C ND RTL IMC 3 0.4
LE PL 26 E ND LP+ NRTL HMC NV NV N LE LPG SICS + + - - - PCIOL 5/60 16 6/60 16 6/36 16 6/24 14 6/12 14 6/12 14 N
10 SOLAI 60 M 1480 RE 3/60 14 C ND RTL IMC 3 VH
LE HM 34 E S NRTL MC NV NV N LE PMG SICS+LR + + + + + APHAKIA HM 20 1/60 20 1/60 20 1/60 16 1/60 16 1/60 16 NP
11 RATHNAM 57 M 1293 RE HM 40 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + - - - PCIOL 6/60 12 6/60 12 6/60 12 6/36 12 6/24 12 6/18 12 N
LE 6/12 12 C ND RTL PCIOL 3 0.4
12 RAJI 65 F 1356 RE HM 28 E ND LP+ NRTL HMC NV NV N RE LPG SICS - + - - - PCIOL 5/60 14 5/60 12 6/60 12 6/60 12 6/36 12 6/24 12 N
LE 6/24 12 C ND RTL PCIOL 3 0.3
13 MALIGAI 55 F 1908 RE PL 38 E S NRTL MC 1 PAS NV N RE PMG COMB + + + - - PCIOL 4/60 18 4/60 16 5/60 14 6/60 14 6/60 14 6/36 14 N
LE 6/60 16 C ND RTL IMC 3 0.4
14 SURYAN 63 M 1460 RE 6/36 18 C ND RTL IMC 3 0.3
LE HM 38 E S NRTL MC NV NV N LE PMG SICS+PI + + - - - PCIOL 5/60 20 6/60 20 6/60 20 6/60 16 6/60 16 6/36 16 N
15 KAMALI 70 F 2701 RE PL 28 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + + - - PCIOL 6/60 18 6/60 18 6/60 18 6/36 16 6/24 14 6/24 14 N
LE 6/24 18 C ND RTL PCIOL 3 0..4
16 SANTHANAM 59 M 4780 RE 6/18 20 C ND RTL PCIOL 3 0.3
LE PL 36 E S NRTL MC NV NV N LE PMG SICS+PI + + - - - PCIOL 5/60 20 5/60 20 6/60 20 6/60 20 6/60 18 6/60 18 N
17 SUNDARI 61 F 1269 RE PL 40 E ND C+F+ NRTL HMC NV NV N RE PLG SICS - + + - - PCIOL 3/60 18 3/60 18 4/60 18 4/60 18 5/60 18 5/60 18 N
LE 6/12 18 C ND RTL PCIOL 3 0.3
18 LALITHA 56 F 1904 RE PL 30 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS + + + - - PCIOL 2/60 16 2/60 16 3/60 14 4/60 14 6/60 14 6/60 14 N
LE 6/18 16 C ND RTL PCIOL 3 0.3
19 PARI 56 M 2360 RE 6/12 18 C ND RTL PCIOL 3 0.3
LE PL 38 E ND C+F+ NRTL MC NV NV N LE PLG ECCE - + - - - PCIOL 5/60 18 5/60 18 6/60 16 6/60 16 6/36 16 6/36 16 N
20 KRISHNAN 69 M 1573 RE 6/18 16 C ND RTL PCIOL 3 0.4
LE HM 28 E ND C+F+ NRTL HMC NV NV N LE PLG SICS + + + - - PCIOL 4/60 20 4/60 16 4/60 16 6/60 16 6/60 16 6/60 16 N
21 KATHIR 51 M 9807 RE HM 28 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS - + - - - PCIOL 3/60 14 6/60 14 6/24 14 6/12 12 6/12 12 6/12 12 N
LE 6/12 12 C ND RTL PCIOL 3 0.3
22 MANIVANNAN 78 M 567 RE PL 30 E ND C+F+ SRTL MC NV NV N RE PLG SICS + + - - - PCIOL 2/60 14 3/60 14 6/60 14 6/36 14 6/24 12 6/12 12 N
LE 6/18 14 C ND RTL PCIOL 3 0.3
23 KUMARI DEVI 60 F 678 RE 6/36 14 C ND RTL IMC 3 0.3
LE HM 30 E S NRTL MC 1 PAS NV N LE PMG COMB + + + - + PCIOL 1/60 18 3/60 18 5/60 18 6/36 16 6/36 16 6/36 16 N
24 VILLALAN 67 M 342 RE 6/24 12 C ND RTL IMC 3 0.3
LE HM 30 E ND C+F+ NRTL HMC NV NV N LE PLG SICS + + - - - PCIOL 4/60 14 6/60 14 6/36 12 6/24 12 6/24 12 6/18 12 N
25 PANDIAMMAL 56 F 1207 RE PL 26 E ND C+F+ NRTL MC NV NV N RE PLG SICS + + - - - PCIOL 3/60 12 3/60 12 4/60 12 6/60 12 6/36 12 6/36 12 N
EYESL NO NAME AGE SEX IP NUM SURGICAL COMPLICATIONSVN IOP CORNEA AC PUPIL LENS GONIO CDR BSCAN DIAGNOSIS SURGERY PO 6TH WK FIELDSIOL POD1 POD3 POD 7 PO 2ND WK PO 4TH WK
SK POI ZD VL PCR VN IOP VN IOP VN IOP VN IOP VN IOP VN IOP
26 MANIVARMAN 59 M 1048 RE 6/24 18 C ND RTL PCIOL 3 0.3
LE HM 28 E ND C+F+ NRTL MC NV NV N LE PLG SICS + + + - - PCIOL 1/60 16 1/60 16 3/60 16 5/60 14 6/60 14 6/36 14 N
27 PARVATHAM 62 F 8902 RE PL 26 E ND C+F+ NRTL HMC NV NV N RE PLG SICS - + - - - PCIOL 4/60 14 6/60 12 6/36 12 6/36 12 6/12 12 6/12 12 N
LE 6/36 18 C ND RTL PCIOL 3 0.3
28 PICHAI 63 M 2123 RE HM 32 E S NRTL MC 1 PAS NV N RE PMG COMB + + + - - PCIOL 3/60 16 4/60 16 6/60 14 6/36 14 6/36 14 6/36 14 N
LE 6/18 18 C ND RTL PCIOL 3 0.3   
29 KOTAI 72 M 12367 RE 5/60 20 C ND RTL IMC 3 0.4
LE PL 26 E ND LP+ NRTL HMC NV NV N LE LPG SICS + + - - - PCIOL 5/60 16 6/60 16 6/36 16 6/24 14 6/12 14 6/12 14 N
30 PACHAI 68 M 1367 RE 5/60 14 C ND RTL IMC 3 VH
LE HM 34 E S NRTL MC NV NV N LE PMG SICS+LR + + + + + APHAKIA HM 20 1/60 20 1/60 20 1/60 16 1/60 16 1/60 16 NP
31 LAKSHMAN 57 M 670 RE HM 40 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + - - - PCIOL 6/60 12 6/60 12 6/60 12 6/36 12 6/24 12 6/18 12 N
LE 6/24 12 C ND RTL PCIOL 3 0.4
32 RAJKUMARI 70 F 1893 RE HM 28 E ND LP+ NRTL HMC NV NV N RE LPG SICS - + + - - PCIOL 5/60 14 5/60 12 6/60 12 6/60 12 6/36 12 6/24 12 N
LE 6/24 12 C ND RTL PCIOL 3 0.3
33 MANOGARI 59 F 1908 RE PL 38 E S NRTL MC 1 PAS NV N RE PMG COMB + + - - - PCIOL 4/60 18 4/60 16 5/60 14 6/60 14 6/60 14 6/36 14 N
LE 6/60 16 C ND RTL IMC 3 0.4
34 VARADAN 63 M 790 RE 6/36 18 C ND RTL IMC 3 0.3
LE HM 38 E S NRTL MC NV NV N LE PMG SICS+PI + + + - - PCIOL 5/60 20 6/60 20 6/60 20 6/60 16 6/60 16 6/36 16 N
35 KAMESWARI 55 F 2701 RE PL 28 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + - - - PCIOL 6/60 18 6/60 18 6/60 18 6/36 16 6/24 14 6/24 14 N
LE 6/24 18 C ND RTL PCIOL 3 0..4
36 SUDARMANI 60 M 1256 RE 6/18 20 C ND RTL PCIOL 3 0.3
LE PL 36 E S NRTL MC NV NV N LE PMG SICS+PI + + - - - PCIOL 5/60 20 5/60 20 6/60 20 6/60 20 6/60 18 6/60 18 N
37 KANAGI 61 F 6789 RE PL 38 E ND C+F+ NRTL HMC NV NV N RE PLG SICS + + + - - PCIOL 3/60 18 3/60 18 4/60 18 4/60 18 5/60 18 5/60 18 N
LE 6/12 18 C ND RTL PCIOL 3 0.3
38 LAKSHMI 56 F 6704 RE PL 30 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS + + - - - PCIOL 2/60 16 2/60 16 3/60 14 4/60 14 6/60 14 6/60 14 N
LE 6/18 16 C ND RTL PCIOL 3 0.3
39 PUSHPPAM 56 F 7845 RE 6/12 18 C ND RTL PCIOL 3 0.3
LE PL 38 E ND C+F+ NRTL MC NV NV N LE PLG ECCE - + - - - PCIOL 5/60 18 5/60 18 6/60 16 6/60 16 6/36 16 6/36 16 N
40 KUPPU 59 M 8967 RE 6/18 16 C ND RTL PCIOL 3 0.4
LE HM 30 E ND C+F+ NRTL HMC NV NV N LE PLG SICS + + + - - PCIOL 4/60 20 4/60 16 4/60 16 6/60 16 6/60 16 6/60 16 N
41 MICHAEL 56 M 589 RE HM 30 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS - + - - - PCIOL 4/60 18 6/60 16 6/24 16 6/12 14 6/12 14 6/12 14 N
LE 6/18 16 C ND RTL PCIOL 3 0.3
42 AMARAN 64 M 1537 RE PL 26 E ND C+F+ SRTL MC NV NV N RE PLG SICS + + - - + PCIOL 2/60 20 3/60 18 6/60 14 6/36 14 6/24 12 6/12 12 N
LE 6/12 18 C ND RTL PCIOL 3 0.3
43 BANUMATHY 59 F 179 RE 6/12 20 C ND RTL IMC 3 0.3
LE HM 28 E S NRTL MC 1 PAS NV N LE PMG COMB + + - - - PCIOL 1/60 18 3/60 18 5/60 18 6/60 16 6/36 16 6/36 16 N
44 VINOLIYA 58 F 114 RE 6/24 18 C ND RTL IMC 3 0.3
LE HM 30 E ND C+F+ NRTL HMC NV NV N LE PLG SICS + + + - - PCIOL 4/60 16 6/60 16 6/36 14 6/24 14 6/24 14 6/18 14 N
45 MANOGAR 56 M 1442 RE PL 26 E ND C+F+ NRTL MC NV NV N RE PLG SICS + + - - - PCIOL 3/60 12 3/60 12 4/60 12 6/60 12 6/36 12 6/36 12 N
LE 6/9 12 C ND RTL PCIOL 3 0.3
46 MURAD 62 M 1705 RE 6/24 18 C ND RTL PCIOL 3 0.3
LE PL 28 E ND C+F+ NRTL MC NV NV N LE PLG SICS + + - - - PCIOL 1/60 18 1/60 16 3/60 16 5/60 14 6/60 14 6/36 14 N
47 PUSHPA 53 F 1879 RE PL 26 E ND C+F+ NRTL HMC NV NV N RE PLG SICS - + - - - PCIOL 4/60 14 6/60 12 6/36 12 6/36 12 6/12 12 6/12 12 N
LE 6/9 16 C ND RTL PCIOL 3 0.3
48 RAZAK 58 M 7890 RE HM 32 E S NRTL MC 1 PAS NV N RE PMG COMB + + + - - PCIOL 2/60 20 3/60 18 5/60 14 6/36 14 6/36 14 6/36 14 N
LE 6/18 20 C ND RTL PCIOL 3 0.3   
49 KANDASAMY 67 M 6790 RE 6/36 16 C ND RTL IMC 3 0.4
LE PL 30 E ND LP+ NRTL HMC NV NV N LE LPG SICS + + - - - PCIOL 5/60 16 6/60 16 6/36 16 6/24 14 6/12 14 6/12 14 N
50 FAROOK 60 M 8903 RE 5/60 18 C ND RTL IMC 3 VH
LE HM 34 E S NRTL MC NV NV N LE PMG SICS+LR + + + + + APHAKIA HM 22 1/60 20 1/60 20 1/60 16 1/60 16 1/60 16 NP
EYESL NO NAME AGE SEX IP NUM                           SURGICAL COMPLICATIONSVN IOP CORNEA AC PUPIL LENS GONIO CDR BSCAN DIAGNOSIS SURGERY PO 6TH WK FIELDSIOL POD1 POD3 POD 7 PO 2ND WK PO 4TH WK
SK POI ZD VL PCR VN IOP VN IOP VN IOP VN IOP VN IOP VN IOP
51 RAGUPATHY 59 M 1293 RE HM 40 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + - - - PCIOL 6/60 12 6/60 12 6/60 12 6/36 12 6/24 12 6/18 12 N
LE 6/12 18 C ND RTL PCIOL 3 0.4
52 RACHEL 65 F 5835 RE HM 28 E ND LP+ NRTL HMC NV NV N RE LPG SICS - + + - - PCIOL 5/60 18 5/60 18 6/60 18 6/60 16 6/36 16 6/24 16 N
LE 6/24 16 C ND RTL PCIOL 3 0.3
53 MARUDAMAL 55 F 7893 RE PL 38 E S NRTL MC 1 PAS NV N RE PMG COMB + + - - - PCIOL 4/60 18 4/60 16 5/60 14 6/60 14 6/60 14 6/36 14 N
LE 6/36 18 C ND RTL IMC 3 0.4
54 SULAIMANN 69 M 45678 RE 6/36 18 C ND RTL IMC 3 0.3
LE HM 38 E S NRTL MC NV NV N LE PMG SICS+PI + + - - + PCIOL 2/60 20 3/60 20 4/60 20 6/60 16 6/60 16 6/36 16 N
55 REBECCA 59 F 4568 RE PL 28 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + + - - PCIOL 6/60 18 6/60 18 6/60 18 6/36 16 6/24 14 6/24 14 N
LE 6/12 18 C ND RTL PCIOL 3 0..4
56 MARI 60 M 4780 RE 6/18 20 C ND RTL PCIOL 3 0.3
LE PL 36 E S NRTL MC NV NV N LE PMG SICS+PI + + - - - PCIOL 4/60 20 5/60 20 6/60 20 6/60 20 6/60 18 6/60 18 N
57 MARIAMMAL 59 F 8763 RE PL 40 E ND C+F+ NRTL HMC NV NV N RE PLG SICS + + + - - PCIOL 3/60 18 3/60 18 4/60 18 4/60 18 5/60 18 5/60 18 N
LE 6/24 14 C ND RTL PCIOL 3 0.3
58 LURDHUAMAL 60 F 9712 RE PL 30 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS + + - - - PCIOL 2/60 16 2/60 16 3/60 14 4/60 14 6/60 14 6/60 14 N
LE 6/12 18 C ND RTL PCIOL 3 0.3
59 PUNIYAKODI 66 M 1579 RE 6/24 18 C ND RTL PCIOL 3 0.3
LE PL 38 E ND C+F+ NRTL MC NV NV N LE PLG ECCE - + + - - PCIOL 4/60 18 5/60 18 6/60 16 6/60 16 6/36 16 6/36 16 N
60 RAM 55 M 288 RE 6/18 16 C ND RTL PCIOL 3 0.4
LE HM 28 E ND C+F+ NRTL HMC NV NV N LE PLG SICS + + - - - PCIOL 4/60 20 4/60 16 4/60 16 6/60 16 6/60 16 6/60 16 N
61 SARAVANAN 55 M 1479 RE HM 30 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS - + + - - PCIOL 4/60 16 6/60 16 6/24 16 6/12 14 6/12 14 6/12 14 N
LE 6/12 18 C ND RTL PCIOL 3 0.3
62 ASOKAN 57 M 146 RE PL 26 E ND C+F+ SRTL MC NV NV N RE PLG SICS + + - - - PCIOL 2/60 18 3/60 18 6/60 18 6/36 16 6/24 16 6/12 16 N
LE 6/18 20 C ND RTL PCIOL 3 0.3
63 BEULA 60 F 2347 RE 6/12 14 C ND RTL IMC 3 0.3
LE HM 28 E S NRTL MC 1 PAS NV N LE PMG COMB + + - - - PCIOL 1/60 18 2/60 18 4/60 18 6/36 16 6/36 16 6/36 16 N
64 RAJKIRAN 60 M 1270 RE 6/24 12 C ND RTL IMC 3 0.3
LE HM 30 E ND C+F+ NRTL HMC NV NV N LE PLG SICS - + - - - PCIOL 4/60 14 6/60 14 6/36 12 6/24 12 6/24 12 6/18 12 N
65 PARVATHAMAL 56 F 4778 RE PL 26 E ND C+F+ NRTL MC NV NV N RE PLG SICS + + + - - PCIOL 3/60 18 3/60 18 4/60 18 6/60 18 6/36 18 6/36 18 N
LE 6/12 14 C ND RTL PCIOL 3 0.3
66 MOSAS 62 M 945 RE 6/24 16 C ND RTL PCIOL 3 0.3
LE HM 28 E ND C+F+ NRTL MC NV NV N LE PLG ECCE + + - - - PCIOL 3/60 16 4/60 16 5/60 16 5/60 14 6/60 14 6/36 14 N
67 RAHAMATH 66 F 4109 RE PL 26 E ND C+F+ NRTL HMC NV NV N RE PLG SICS - + + - - PCIOL 4/60 14 6/60 12 6/36 12 6/36 12 6/12 12 6/12 12 N
LE 6/36 18 C ND RTL PCIOL 3 0.3
68 HUSSAIN 58 M 690 RE HM 32 E S NRTL MC 1 PAS NV N RE PMG COMB + + - - - PCIOL 2/60 20 4/60 18 6/60 16 6/36 16 6/36 14 6/36 14 N
LE 6/18 18 C ND RTL PCIOL 3 0.3   
69 KIRUBA 55 M 753 RE 6/12 16 C ND RTL PCIOL 3 0.4
LE PL 26 E ND LP+ NRTL HMC NV NV N LE LPG SICS + + + - - PCIOL 5/60 16 6/60 16 6/36 16 6/24 14 6/12 14 6/12 14 N
70 MOORTHY 52 M 701 RE 6/9 18 C ND RTL PCIOL 3 0.3
LE 1/60 40 E S NRTL IMC SL NV VH N LE SLIG(SL) SICS+LR + + + + + APHAKIA HM 20 HM 20 1/60 20 1/60 16 1/60 16 1/60 16 NP
71 RAMAMURTHY 57 M 9023 RE HM 40 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + + - - PCIOL 6/60 12 6/60 12 6/60 12 6/36 12 6/24 12 6/18 12 N
LE 6/12 12 C ND RTL PCIOL 3 0.4
72 VISALAM 65 F 8063 RE HM 28 E ND LP+ NRTL HMC NV NV N RE LPG SICS - + + - - PCIOL 5/60 14 5/60 12 6/60 12 6/60 12 6/36 12 6/24 12 N
LE 6/12 20 C ND RTL PCIOL 3 0.3
73 KUMUDA 55 F 277 RE PL 38 E S NRTL MC 1 PAS NV N RE PMG COMB + + - - + PCIOL 4/60 18 4/60 16 5/60 14 6/60 14 6/60 14 6/36 14 N
LE 6/24 20 C ND RTL IMC 3 0.4
74 VENKATRAM 57 M 366 RE 6/18 18 C ND RTL IMC 3 0.3
LE HM 38 E S NRTL MC NV NV N LE PMG SICS+PI + + - - - PCIOL 5/60 20 6/60 20 6/60 20 6/60 16 6/60 16 6/36 16 N
75 KOMALAM 56 F 886 RE PL 28 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + + - - PCIOL 6/60 18 6/60 18 6/60 18 6/36 16 6/24 14 6/24 14 N
LE 6/18 18 C ND RTL PCIOL 3 0..4
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76 SABARI 59 M 770 RE 6/18 20 C ND RTL PCIOL 3 0.3
LE PL 40 E S NRTL MC NV NV N LE PMG SICS+PI + + - - - PCIOL 5/60 20 5/60 20 6/60 20 6/60 20 6/60 18 6/60 18 N
77 GUNAVATHY 55 F 841 RE PL 40 E ND C+F+ NRTL HMC NV NV N RE PLG SICS + + + - - PCIOL 3/60 18 3/60 18 4/60 18 4/60 18 5/60 18 5/60 18 N
LE 6/12 18 C ND RTL PCIOL 3 0.3
78 LISAMARY 55 F 976 RE PL 30 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS + + + - - PCIOL 2/60 16 2/60 16 3/60 14 4/60 14 6/60 14 6/60 14 N
LE 6/18 16 C ND RTL PCIOL 3 0.3
79 PARTHIBAN 60 M 456 RE 6/12 18 C ND RTL PCIOL 3 0.3
LE PL 38 E ND C+F+ NRTL MC NV NV N LE PLG ECCE - + - - - PCIOL 5/60 20 5/60 20 6/60 18 6/60 18 6/36 16 6/36 16 N
80 SUBBU 52 M 775 RE 6/18 16 C ND RTL PCIOL 3 0.4
LE HM 28 E ND C+F+ NRTL HMC NV NV N LE PLG SICS + + + - + PCIOL 2/60 20 3/60 16 4/60 16 6/60 16 6/60 16 6/60 16 N
81 THULASIDARAN 56 M 237 RE HM 30 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS - + - - - PCIOL 4/60 20 6/60 20 6/24 20 6/12 18 6/12 18 6/12 18 N
LE 6/12 12 C ND RTL PCIOL 3 0.3
82 PASUPATHY 66 M 145 RE PL 26 E ND C+F+ SRTL MC NV NV N RE PLG SICS + + - - - PCIOL 2/60 14 3/60 14 6/60 14 6/36 14 6/24 12 6/12 12 N
LE 6/18 14 C ND RTL PCIOL 3 0.3
83 GOMATHI 58 F 358 RE 6/12 14 C ND RTL IMC 3 0.3
LE HM 28 E S NRTL MC 1 PAS NV N LE PMG COMB + + - - - PCIOL 1/60 18 1/60 18 3/60 18 6/60 16 6/36 16 6/36 16 N
84 SITARAMAN 58 M 557 RE 6/24 12 C ND RTL IMC 3 0.3
LE HM 30 E ND C+F+ NRTL HMC NV NV N LE PLG SICS - + + - + PCIOL 4/60 14 6/60 14 6/36 12 6/24 12 6/24 12 6/18 12 N
85 JANAKI 56 F 662 RE PL 26 E ND C+F+ NRTL MC NV NV N RE PLG SICS + + - - - PCIOL 3/60 12 3/60 12 4/60 12 6/60 12 6/36 12 6/36 12 N
LE 6/12 14 C ND RTL PCIOL 3 0.3
86 KADHAR 62 M 339 RE 6/24 16 C ND RTL PCIOL 3 0.3
LE HM 28 E ND C+F+ NRTL MC NV NV N LE PLG SICS + + - - - PCIOL 1/60 16 1/60 16 3/60 16 5/60 14 6/60 14 6/36 14 N
87 RAMANI 66 F 876 RE PL 26 E ND C+F+ NRTL HMC NV NV N RE PLG SICS - + + - - PCIOL 4/60 14 6/60 12 6/36 12 6/36 12 6/12 12 6/12 12 N
LE 6/9 18 C ND RTL PCIOL 3 0.3
88 SUBRAMANI 58 M 712 RE HM 32 E S NRTL MC 1 PAS NV N RE PMG COMB + + - - - PCIOL 3/60 16 4/60 16 6/60 14 6/36 14 6/36 14 6/36 14 N
LE 6/18 18 C ND RTL PCIOL 3 0.3   
89 PRANESHWAR 52 M 12367 RE 6/12 20 C ND RTL IMC 3 0.4
LE PL 26 E ND LP+ NRTL HMC NV NV N LE LPG SICS + + + - - PCIOL 5/60 16 6/60 16 6/36 16 6/24 14 6/12 14 6/12 14 N
90 PANEER 59 M 775 RE 6/60 14 C ND RTL IMC 3 0.3
LE HM 42 E S NRTL MC NV NV N LE PMG SICS+LR + + + + + APHAKIA HM 20 1/60 20 1/60 20 1/60 16 1/60 16 1/60 16 NP
91 GOPAL 57 M 7721 RE HM 40 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + - - - PCIOL 6/60 12 6/60 12 6/60 12 6/36 12 6/24 12 6/18 12 N
LE 6/12 12 C ND RTL PCIOL 3 0.4
92 PARAMU 65 F 5790 RE HM 28 E ND LP+ NRTL HMC NV NV N RE LPG SICS - + + - - PCIOL 4/60 18 5/60 18 6/60 16 6/60 16 6/36 16 6/24 16 N
LE 6/24 18 C ND RTL PCIOL 3 0.3
93 SUDARVIZHI 51 F 1908 RE PL 38 E S NRTL MC 1 PAS NV N RE PMG COMB + + - - - PCIOL 4/60 18 4/60 16 5/60 14 6/60 14 6/60 14 6/36 14 N
LE 6/12 16 C ND RTL IMC 3 0.4
94 RAJAVELU 63 M 953 RE 6/36 18 C ND RTL IMC 3 0.3
LE HM 38 E S NRTL MC NV NV N LE PMG SICS+PI + + - - - PCIOL 5/60 20 6/60 20 6/60 20 6/60 16 6/60 16 6/36 16 N
95 SEETHA 70 F 8999 RE PL 28 E ND C+F+ NRTL HMC NV NV N RE PLG ECCE - + + - - PCIOL 6/60 18 6/60 18 6/60 18 6/36 16 6/24 14 6/24 14 N
LE 6/24 18 C ND RTL PCIOL 3 0..4
96 ZAKEER 59 M 566 RE 6/18 20 C ND RTL PCIOL 3 0.3
LE PL 36 E S NRTL MC NV NV N LE PMG SICS+PI + + - - - PCIOL 5/60 20 5/60 20 6/60 20 6/60 20 6/60 18 6/60 18 N
97 KAVITHA 52 F 1269 RE PL 40 E ND C+F+ NRTL HMC NV NV N RE PLG SICS + + + - - PCIOL 3/60 18 3/60 18 4/60 18 4/60 18 5/60 18 5/60 18 N
LE 6/12 18 C ND RTL PCIOL 3 0.3
98 LALITHA 60 F 133 RE PL 30 E  ND C+ F+ NRTL HMC NV NV N RE PLG SICS + + + - - PCIOL 2/60 16 2/60 16 3/60 14 4/60 14 6/60 14 6/60 14 N
LE 6/18 16 C ND RTL PCIOL 3 0.3
99 MALAIAPAN 56 M 9034 RE 6/12 20 C ND RTL PCIOL 3 0.3
LE PL 38 E ND C+F+ NRTL MC NV NV N LE PLG ECCE - + - - - PCIOL 5/60 18 5/60 18 6/60 16 6/60 16 6/36 16 6/36 16 N
100 LOGANATHAN 56 M 3461 RE 6/18 16 C ND RTL PCIOL 3 0.4
LE HM 28 E ND C+F+ NRTL HMC NV NV N LE PLG SICS + + + - - PCIOL 4/60 20 4/60 16 4/60 16 6/60 16 6/60 16 6/60 16 N
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